Skip to main content

Research in Review

Research in Review

Authored by

JCP Editors


J Clin Pathways. 2018;4(10):19-20.

ASCO: CMS Proposed Rule Will Likely Harm Patients With Cancer

The American Society of Clinical Oncology has expressed opposition toward the new Centers for Medicare & Medicaid Services proposed rule to reduce the number of prescription drugs made available to Medicare beneficiaries with chronic, potentially life-threatening illnesses.

Read More


Treatment Noncompliance, Adverse Outcomes Due to Financial Toxicity in Cancer

Patients with cancer who experience financial toxicity are more likely to report noncompliance with medication and forgoing doctor’s visits.

Read More


Lung Cancer Care Disparities in Academic, Community Centers 

A greater increase in survival over a 12-year span was observed for patients with non-small cell lung cancer treated in academic centers compared with community centers.

Read More


Cardiovascular Toxicity Associated With Immune Checkpoint Inhibitors

Cancer treatment with immune checkpoint inhibitors can lead to life-threatening myocarditis, pericardial diseases, and temporal arteritis with risk of blindness.

Read More

Back to Top